LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.320
+0.030 (2.33%)
At close: May 28, 2025, 4:00 PM
1.300
-0.020 (-1.52%)
After-hours: May 28, 2025, 4:00 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $34.72 million as of May 28, 2025. Its market cap has decreased by -57.53% in one year.
Market Cap
34.72M
Enterprise Value
-31.52M
1-Year Change
-57.53%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $34.72M, a decrease of -90.87%. That is a compound annual growth rate of -43.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 33.93M | 35.68% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.01B |
| Johnson & Johnson | 368.59B |
| AbbVie | 327.54B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 263.82B |
| Abbott Laboratories | 231.64B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |